U01.11.029 Osteoporosis

Learning Objectives

  • Explain the pathophysiology of Osteoporosis, specifically the imbalance between osteoblasts and osteoclasts.
  • Identify the diagnostic criteria (T-score) and screening guidelines for bone mineral density.
  • List key risk factors, including hormonal, lifestyle, and pharmacological causes.
  • Recognize the clinical presentation of vertebral compression fractures and other common fracture sites.

1. Pathophysiology and Bone Loss

Osteoporosis is characterized by a reduction in both trabecular (spongy) and cortical bone mass. Crucially, the bone that remains is normally mineralized—there is just less of it.

  • Mechanism: Primarily due to increased bone resorption. This is often triggered by decreased estrogen levels (menopause), which normally limits osteoclast activity.
  • Laboratory Values: A high-yield Step 1 fact is that Serum Calcium, Phosphate, and PTH are typically NORMAL in primary osteoporosis.
  • Secondary Causes:
    • Drugs: Long-term Corticosteroids, Anticonvulsants, Heparin, and PPIs.
    • Conditions: Hyperparathyroidism, Multiple Myeloma, Malabsorption, and Hyperthyroidism.
    • Environment: Prolonged microgravity (space travel) or immobilization.


2. Diagnosis and Screening

Osteoporosis is often “silent” until a fracture occurs. Screening is essential for early detection.

  • DEXA Scan: Dual-energy X-ray absorptiometry at the lumbar spine, total hip, and femoral neck.
  • T-score \le -2.5: Diagnostic for Osteoporosis. (T-score between -1.0 and -2.5 is Osteopenia).
  • Fragility Fracture: A diagnosis can be made regardless of T-score if a patient suffers a fracture from minimal trauma (e.g., falling from standing height).
  • Screening: Recommended for all females \ge 65 years old.


3. Clinical Consequences

Loss of bone density leads to characteristic skeletal changes and “fragility” fractures.

  • Vertebral Compression Fracture: Presents with acute back pain, loss of height, and Kyphosis (Dowager’s hump).
  • Colles Fracture: Fracture of the distal radius (common in FOOSH injuries).
  • Hip Fractures: Specifically of the femoral neck; associated with high morbidity and mortality in the elderly.

 


Pharmacology Summary (High Yield):

  • Bisphosphonates: First-line; inhibit osteoclasts (side effect: corrosive esophagitis).
  • Teriparatide: Recombinant PTH; anabolic (builds bone) if given in pulsatile/intermittent doses.
  • Denosumab: Monoclonal antibody against RANKL (mimics OPG).
  • SERMs (Raloxifene): Estrogen agonist in bone, antagonist in breast/uterus.

Activity: Osteoporosis vs. Other Bone Diseases

Quick Mnemonics:
Osteoporosis: Porous bone (the labs are fine, the Ports are empty).
DEXA: Density Exam for X-ray Analysis.

Activity: